FTUS
FTXH icon

Flow Traders U.S.’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Flow Traders U.S.’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,090
Closed -$652K – 858
2021
Q4 		$652K Buy
+24,090
New +$633K 0.03% 401

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Flow Traders U.S.'s FTXH Position: Q1 2022 in Review

Flow Traders U.S. sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2022, closing a stake of 24,090 shares — an estimated $652K sold.

Flow Traders U.S. first reported a position in FTXH in Q4 2021 and held it in 1 quarter. The position peaked at $652K in Q4 2021. 17 funds tracked by Wall St. Rank hold FTXH as of Q1 2022.

  • Flow Traders U.S. reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q1 2022 after selling out during the quarter.
  • Flow Traders U.S. sold 24,090 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2022, an estimated $652K.
  • Flow Traders U.S. first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2021 and held it in 1 quarter.
  • Flow Traders U.S.'s First Trust Nasdaq Pharmaceuticals ETF position peaked at $652K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2022.

Based on Flow Traders U.S.'s 13F filing for Q1 2022, filed 13 May 2022.